CEMI News Alert Chembio Diagnostics (CEMI) 3.98 12/25/2014 0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chembio Diagnostics (CEMI) 3.98 $CEMI

Chembio to develop multiplex Point-of-Care Test for Influenza Immunity in partnership with the US CDC
M2 - Tue Nov 25, 8:50AM CST
Diagnostic tests company Chembio Diagnostics (NasdaqCM:CEMI) on Monday reported a follow-on, milestone-based development agreement for a multiplex POC influenza immunity test utilising its patented Dual Path Platform (DPP) technology in partnership with an undisclosed company and the US Centers for Disease Control and Prevention (CDC).
CEMI: 3.98 (+0.08)

Chembio Signs Agreement With CDC Contractor to Develop a Multiplex Point-of-Care Test for Influenza Immunity
GlobeNewswire - Mon Nov 24, 7:50AM CST
Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into a follow-on, milestone-based development agreement with a private contracting organization acting on behalf of the United States Centers for Disease Control and Prevention (CDC), for a multiplex POC influenza immunity test utilizing Chembio's patented Dual Path Platform (DPP) technology.
CEMI: 3.98 (+0.08)

Cepheid receives grant to develop Ebola test
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 7:11AM CST

CPHD: 53.39 (+0.51), CEMI: 3.98 (+0.08)

Chembio Diagnostics' (CEMI) CEO John Sperzel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 11:04AM CST

CEMI: 3.98 (+0.08)

Chembio Diagnostics misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 7:56AM CST

CEMI: 3.98 (+0.08)

Chembio Diagnostics Reports Third Quarter 2014 Financial Results
GlobeNewswire - Thu Nov 06, 7:50AM CST
Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today reported financial results for the third quarter and nine months ended September 30, 2014.
CEMI: 3.98 (+0.08)

Chembio to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, November 6, 2014
ACCESSWIRE - Wed Nov 05, 3:57PM CST
MEDFORD, NY / ACCESSWIRE / November 5, 2014 / Chembio Diagnostics, Inc. (NASDAQ: CEMI) will host a conference call and live webcast to discuss the results of the third quarter 2014, to be held Thursday, November 6, 2014 at 10:00 AM Eastern Time.
CEMI: 3.98 (+0.08)

Chembio HIV 1/2 rapid test gets CLIA waiver
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 2:58PM CST

CEMI: 3.98 (+0.08)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 8:18AM CDT

KNDI: 12.90 (+0.99), ALU: 3.67 (+0.03), CDTI: 1.87 (+0.01), VSR: 3.01 (-0.03), NBG: 1.95 (+0.06), ARAY: 7.54 (+0.19), GLUU: 4.07 (-0.04), OCLS: 1.50 (+0.01), CEMI: 3.98 (+0.08), TTWO: 28.60 (+0.18), PRXL: 56.48 (+0.57), RDN: 16.78 (+0.18), BBD: 13.28 (+0.05), NVAX: 5.81 (+0.18), APT: 2.55 (-0.03), BBSI: 28.34 (+0.38), LAKE: 8.94 (+0.07), GOL: 5.16 (-0.04), TASR: 26.86 (+0.84), AUY: 3.89 (+0.15), PCRX: 92.09 (-1.79), ITUB: 13.10 (+0.21)

Chembio's DPP(R) HIV 1/2 Assay Receives CLIA Waiver From FDA
GlobeNewswire - Thu Oct 30, 7:50AM CDT
Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests and technology, today announced that the U.S. Food and Drug Administration (FDA) granted a CLIA Waiver for the Company's DPP HIV 1/2 Assay. Chembio's DPP HIV 1/2 Assay was FDA-approved previously, and the CLIA Waiver will allow Chembio to expand into important new channels that are closest to patient care including physician-office-lab (POL) facilities, clinics and other community healthcare providers.
CEMI: 3.98 (+0.08)

Chembio to develop POC diagnostic tests for dengue fever virus and specific type of cancer with DPP technology
M2 - Wed Oct 29, 5:25AM CDT
Diagnostic tests company Chembio Diagnostics (NasdaqCM:CEMI) reported on Tuesday the launch of agreements to develop a POC diagnostic test to detect dengue fever virus plus a POC diagnostic test for a type of cancer.
CEMI: 3.98 (+0.08)

Nasdaq stocks posting largest volume increases
AP - Tue Oct 28, 5:14PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
LAYN: 10.11 (+0.25), TRNX: 25.68 (+0.13), DRRX: 0.81 (-0.01), CEMI: 3.98 (+0.08), PBCP: 10.46 (-0.04), PTIE: 2.01 (-0.02), AMDA: 0.64 (-0.01)

Chembio Announces Agreements to Develop Point-of-Care Diagnostic Tests for Dengue Fever Virus and a Specific Type of Cancer
GlobeNewswire - Tue Oct 28, 7:50AM CDT
Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that on October 27, 2014 it entered into an agreement to develop a POC diagnostic test for dengue fever virus. The Company also announced that it has entered into an agreement with an international diagnostics company to develop a POC diagnostic test for a type of cancer. Both development projects will incorporate Chembio's patented DPP technology. Under the terms of the agreements, financial details and the names of the collaborators are not being disclosed.
CEMI: 3.98 (+0.08)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 11:49AM CDT

GFA: 1.52 (-0.04), FST: 0.34 (-0.02), ZAZA: 3.20 (+0.70), EBR: 2.09 (+0.01), VTAE: 19.20 (+0.02), XGTI: 0.95 (-0.04), VBIV: 3.06 (-0.14), DRRX: 0.81 (-0.01), CEMI: 3.98 (+0.08), PBR: 7.60 (-0.11), CBDE: 0.90 (+0.06), OMEX: 0.99 (+0.02), LAYN: 10.11 (+0.25), SRPT: 13.88 (+0.47), CNIT: 3.58 (+0.07), AKBA: 11.23 (-0.31), CTP: 14.57 (-0.18), VPCO: 1.30 (-0.01), PTIE: 2.01 (-0.02)

Chembio Partners With Integrated BioTherapeutics, Inc. to Develop Point-of-Care Diagnostic Tests for Ebola and Febrile Illness
GlobeNewswire - Mon Oct 27, 7:50AM CDT
Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into an exclusive agreement with Integrated BioTherapeutics, Inc. (IBT), a biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases. Under the terms of the agreement, Chembio will combine its patented DPP technology with IBT's proprietary Ebola reagents to develop POC diagnostic tests for Ebola and febrile illness. Chembio will have exclusive rights to any POC product developed through this agreement. Financial terms of the agreement were not disclosed.
CEMI: 3.98 (+0.08)

Chembio reports November 6
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 12:14PM CDT

CEMI: 3.98 (+0.08)

Chembio to Host Conference Call to Discuss Third Quarter 2014 Financial Results
GlobeNewswire - Thu Oct 23, 7:50AM CDT
Chembio Diagnostics, Inc. (Nasdaq:CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that the Company will release financial results for the third quarter of 2014, before the opening of the market on Thursday, November 6, 2014. The Company's 10-Q and earnings press release will be available at 9:15a.m. on our web site.
CEMI: 3.98 (+0.08)

Chembio Diagnostics Reports Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 07, 8:31AM CDT
Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today reported financial results for the second quarter ended June 30, 2014.
CEMI: 3.98 (+0.08)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 100

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
Chicago Kertész Show Puts Photography's Quiet Giant First

Updated Category News Views 112

A fork, a plate, and a sharp eye can outlast plenty of louder art. Leica Gallery Chicago is putting that proposition on the wall with André Kertész: The Master, opening December 4, 2026 and running through January 17, 2027. More than thirty signature works is not a sprawling museum survey, and frankly that may be the point. Kertész did not need grand scale to make his...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 139

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 94

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
AMP Pushes Debt Wall to 2029 With €1.3B Green Notes

Updated Category News Views 108

A Refinancing With Some Actual Breathing Room Metal cans may be boring, but a debt wall arriving in 2028 is not—and Ardagh Metal Packaging has moved that problem down the road. AMP priced €1.3 billion of senior secured floating-rate green notes on November 20, 2026. The proceeds are earmarked to redeem $600 million of senior secured green notes due in 2028 and €450...

Continue Reading
Teachstone’s Bronze Award Puts Classroom Quality in Focus

Updated Category News Views 36

Small Classroom Moments Finally Get Their Due A child’s hesitant question can disappear in the noise of a busy classroom, which is precisely why Teachstone’s latest recognition deserves more than the usual polite golf clap. The Charlottesville-based Certified B Corporation received a Bronze Anthem Award for its “From Measurement to Momentum” initiative, in the...

Continue Reading
Shenzhen’s 50-Year Message Carries Real Trade Weight

Updated Category News Views 68

A city once framed as a frontier fishing village is being presented as China’s sharpest recent economic before-and-after picture. At the welcome dinner for the 33rd APEC Economic Leaders’ Meeting in Shenzhen, President Xi Jinping gave guests a compact geographic guide to China’s past: Xi’an for thousands of years, Beijing for 500 years, Shanghai for 100 years, and...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 127

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 65

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading

Top 5 Most Recently Viewed Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 420

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
BW LPG Limited Welcomes BW Chinook: A Significant Milestone

Updated Category News Views 180

Significant Acquisition by BW LPG Limited BW LPG Limited has recently taken a remarkable step in enhancing its fleet and operational capabilities. The company announced the acquisition of the vessel BW Chinook, marking an important milestone in its ongoing strategy to strengthen its position in the global LPG market. Details of the Vessel Delivery Following a stock...

Continue Reading
COMAC's Expansion: New Hong Kong Office and Maintenance Deal

Updated Category News Views 175

COMAC's Global Expansion Efforts Chinese planemaker COMAC has taken a significant step in its quest to enter the global passenger jet market by inaugurating its second international office in Hong Kong. This move aligns with their strategy to provide enhanced services and establish a stronger footprint outside mainland China. The opening not only symbolizes growth but...

Continue Reading
Torrid Holdings CEO Lisa Harper Makes Strategic Stock Move

Updated Category News Views 415

Lisa Harper's Recent Sale of Company Shares Lisa Harper, the CEO of Torrid Holdings Inc. (NYSE: CURV), has recently sold shares worth $283,909, according to a filing with the Securities and Exchange Commission. In this transaction, she sold 74,713 shares at a price of $3.80 each. This sale is part of her exercise of the underwriters' option to purchase additional shares...

Continue Reading
Getty Images Plans Q3 2024 Financial Results Release Date

Updated Category News Views 102

Getty Images Announces Q3 2024 Financial Results Date Getty Images Holdings, Inc. (NYSE: GETY), a leader in the global visual content industry, is gearing up to share its financial results for the third quarter of 2024. The results will be unveiled right after market closing on November 7, 2024. This announcement signals an important moment for stakeholders keeping a...

Continue Reading